| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $359.3M | — | +15.7% |
| Cost of Revenue | $71.5M | — | +10.1% |
| Gross Profit | $287.8M | — | +17.1% |
| R&D Expense | $85.6M | — | -2.3% |
| SG&A Expense | $68.7M | — | +23.5% |
| Operating Income | -$15.7M | — | +56.8% |
| Pre-tax Income | -$11.0M | — | +60.4% |
| Income Tax | -$1.9M | — | -135.5% |
| Net Income | -$9.1M | — | +72.4% |
| EPS (Basic) | -$0.06 | — | +72.7% |
| EPS (Diluted) | -$0.06 | — | +72.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $386.0M | -19.7% | +23.0% |
| Short-term Investments | $205.5M | -28.6% | -18.8% |
| Accounts Receivable | $184.7M | -35.8% | +14.3% |
| Current Assets | $901.4M | -22.8% | +10.4% |
| Total Assets | $2.11B | -5.8% | +8.2% |
| Current Liabilities | $807.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $76.8M | — | +16.2% |
| Capital Expenditures | $2.9M | — | -27.4% |
| Investing Cash Flow | -$55.0M | — | +13.4% |
| Financing Cash Flow | -$109.7M | — | +13.2% |
| Free Cash Flow | $73.8M | — | +19.1% |
| +17.7% |
| Total Liabilities | $908.1M | -7.0% | +18.4% |
| Stockholders' Equity | $1.20B | -4.9% | +1.6% |